Mar 18, 2021

OICR appoints Dr. Steven Gallinger as Head, Clinical Translation

Sep 24, 2020

Clinical study simplifies precision medicine for pancreatic cancer patients

Jul 24, 2020

OICR research leads to new pancreatic cancer clinical trial with aim to change the standard of care for patients

Mar 24, 2020

Teaming up to decode DNA damage repair

Jan 13, 2020

Unique Toronto-based clinical trial reveals new subtypes of advanced pancreatic cancer

Jun 26, 2019

Patterns in pancreatic cancer samples lead to better prognostic power

May 30, 2019

Predicting the course of pancreatic cancer

Jan 25, 2019

Study reveals mechanism driving spread of advanced pancreatic cancer

Mar 06, 2018

Canadian pancreatic cancer research team provides personalized medicine, new hope to patients

Jan 30, 2018

Early results from COMPASS trial demonstrate benefits of using genomic sequencing to guide treatment for pancreatic cancer

Sep 29, 2017

OICR 2016/17 Annual Report

May 25, 2017

OICR launches five all-star teams of Ontario scientists to tackle some of the deadliest forms of cancer

May 25, 2017

OICR launches five large-scale Ontario research initiatives to combat some of the most deadly cancers

Feb 10, 2017

OICR researchers to be part of Cancer Research UK’s Grand Challenge helping to answer cancer’s biggest questions

Oct 27, 2016

OICR’s Transformative Pathology Program contributes to recent PanCuRx findings

Oct 21, 2016

OICR-led study finds four unique genomic signatures in pancreas cancer, uncovers potential of immunotherapies

Oct 12, 2016

New findings challenge current view of how pancreas cancer develops

Jun 01, 2015

The Ontario Institute for Cancer Research invests $4.6 million to support pancreatic cancer research